Example: Heart Attack
Clinical Trials Sponsored by Health Outcomes Worldwide
Total 1 results
-
NCT04869774Not yet recruitingSurgery--Complications | Surgical Site Infection | Colorectal Surgery | Mobile Applications
We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Show vendors
Sponsors and Collaborators
- AstraZeneca
- Institute of Biomedical Sciences, SUND, University of Copenhagen
- Novartis Pharmaceuticals
- Cairo University
- National Cancer Institute (NCI)
- Ministry of public Health Afghanistan
- Tallahassee Orthopedic Clinic
- Repertoire Immune Medicines
- Pfizer
- MMAS-8 with permission from Dr Donald Morisky. as written below
- Mayo Clinic
- M.D. Anderson Cancer Center
- Assiut University
- Malecare
- Clinique Belledonne - Grenoble
- Pediatric Blood and Marrow Transplant Consortium
- Touro University, California
- Assistance Publique - Hôpitaux de Paris
- Florida
- GlaxoSmithKline
- View Full List
Medical Conditions
- Breast Cancer
- Pharmacokinetics of Diphenhydramine
- Prostate Cancer
- Asthma
- Oral Infection
- Any Advanced Solid Tumors
- Stroke
- Parodontitis Chronic
- Hypertension
- HIV Infections
- Leber Hereditary Optic Neuropathy
- Child
- Traumatic Femoral Fractures
- Coronary Artery Disease
- Obesity
- PRP and Physiotherapy
- Malabsorption
- Depression
- Schistosomiasis haematobia
- Pain
- View Full List
Drug Interventions
- Prednisone
- Naltrexone + ARV's
- Dexamethasone
- Sunscreen oil with 6% Bemotrizinol
- Levonorgestrel 1.5mg
- BrentuximabVedotin (BV)
- Docetaxel
- Carboplatin
- Cisplatin
- 0.5mg intraocular Ranibizumab (Lucentis)
- RO7303359
- SCH 420814 100 mg
- Bevacizumab
- tobramycin inhalation
- Paclitaxel
- EDI048
- Capecitabine
- Gemcitabine
- Cyclophosphamide
- Theophylline 400 mg
- View Full List
CROs by country
- Contract Research Organizations in Albania
- Contract Research Organizations in Angola
- Contract Research Organizations in Australia
- Contract Research Organizations in Bulgaria
- Contract Research Organizations in Cambodia
- Contract Research Organizations in Colombia
- Contract Research Organizations in Germany
- Contract Research Organizations in Ireland
- Contract Research Organizations in Russia
- Contract Research Organizations in Serbia
- Contract Research Organizations in Taiwan
- Contract Research Organizations in Türkiye
- Contract Research Organizations in Zambia
- CRO list by country